Page last updated: 2024-12-10

1,6-dichloro-1,6-dideoxyfructose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1,6-dichloro-1,6-dideoxyfructose (1,6-DDF) is a **synthetic derivative of fructose** that has proven valuable in various research areas. Here's a breakdown of its key features and importance:

**Structure and Properties:**

* **Modified Sugar:** 1,6-DDF differs from fructose by having two chlorine atoms replacing the hydroxyl groups at the 1st and 6th carbons, creating a **deoxy sugar**.
* **Chemical Stability:** The chlorine substituents contribute to its **stability and resistance to hydrolysis**.
* **Versatile Precursor:** 1,6-DDF can be **converted into a range of modified sugars and sugar-based compounds** with potential applications in drug discovery and materials science.

**Research Importance:**

1. **Glycosidase Inhibition:** 1,6-DDF acts as a **potent inhibitor of glycosidases**, enzymes responsible for breaking down carbohydrates. This makes it a valuable tool for studying glycosidase function, mechanism, and potential therapeutic applications.

2. **Carbohydrate Analog Design:** 1,6-DDF serves as a **building block for creating novel carbohydrate analogs**, which are molecules with modified structures that mimic the properties of natural sugars. These analogs have applications in:
* **Drug discovery:** Developing new drugs targeting carbohydrate-related processes, like viral infections and cancer.
* **Materials science:** Designing novel materials with specific properties for biocompatible coatings, drug delivery systems, and biosensors.

3. **Probing Enzyme Specificity:** 1,6-DDF can help researchers **differentiate between the activity of different glycosidase enzymes**. This is achieved by observing how enzymes process 1,6-DDF compared to natural substrates, revealing their specific preferences and substrate binding mechanisms.

4. **Understanding Carbohydrate Metabolism:** 1,6-DDF can be used to **study the pathways of carbohydrate metabolism** by investigating how its presence impacts the activity of various enzymes involved in these pathways.

5. **Glycoconjugate Synthesis:** 1,6-DDF can be used to **prepare complex glycoconjugates**, which are compounds consisting of a sugar molecule linked to a non-sugar molecule (like a protein or lipid). These conjugates play crucial roles in cell signaling, recognition, and immunity, making them valuable for research into these areas.

**Overall, 1,6-dichloro-1,6-dideoxyfructose provides a powerful tool for researchers exploring carbohydrate chemistry, enzymology, and the development of novel sugar-based compounds with diverse applications.**

Cross-References

ID SourceID
PubMed CID3081555
SCHEMBL ID3911954
MeSH IDM0165764

Synonyms (10)

Synonym
1,6-dideoxy-1,6-dichlorofructose
4v097wm1a8 ,
unii-4v097wm1a8
69414-08-0
d-fructose, 1,6-dichloro-1,6-dideoxy-
1,6-dichloro-1,6-dideoxyfructose
SCHEMBL3911954
DTXSID50219569
1,6-dichloro-1,6-di-deoxyfructose
Q27260536
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]